452 results on '"Ringel, Yehuda"'
Search Results
2. Mesenteric panniculitis is associated with cardiovascular risk-factors: A case-control study
3. Endoscopic findings and esophageal cancer incidence among Fanconi Anemia patients participating in an endoscopic surveillance program
4. Upadacitinib for Acute Severe Ulcerative Colitis
5. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
6. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities
7. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders
8. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
9. Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects
10. Development and validation of a prediction model for histologic progression in patients with nondysplastic Barrett's esophagus
11. Use of probiotics in prevention and treatment of patients with Clostridium difficile infection
12. Probiotics in functional bowel disorders
13. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders
14. DEVELOPMENT AND VALIDATION OF PREDICTION MODEL FOR HISTOLOGIC PROGRESSION IN PATIENTS WITH BARRETT'S ESOPHAGUS
15. 551: ANTI-INFLAMATORY EFFECT OF A RATIONALLY-DESIGNED LIVE BACTERIAL CONSORTIUM BASED ON MICROBIOME FUNCTIONAL GENOMIC ANALYSIS FOR TREATMENT OF IBD
16. 14 PAIN-REDUCTION EFFECT OF A RATIONALLY-DESIGNED LIVE BACTERIAL CONSORTIUM FOR TREATMENT OF IBS BASED ON MICROBIOME FUNCTIONAL GENOMICS ANALYSIS
17. Tu1704 A 1470 NM DIODE LASER DEVICE FOR TREATMENT OF FECAL INCONTINENCE: RESULTS OF A PRECLINICAL STUDY IN A PORCINE MODEL
18. Burden of Gastrointestinal Disease in the United States: 2012 Update
19. Alterations in the Intestinal Microbiota and Functional Bowel Symptoms
20. Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome
21. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial
22. Noninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans
23. BMC322- A RATIONALLY-DESIGNED LIVE BACTERIAL CONSORTIUM BASED ON MICROBIOME FUNCTIONAL GENOMIC ANALYSIS FOR TREATMENT OF IBD
24. Randomized, Controlled Trial Shows Biofeedback to be Superior to Alternative Treatments for Patients with Pelvic Floor Dyssynergia-Type Constipation
25. Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study
26. Treatment of functional diarrhea
27. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity
28. S0308 Prep-Free Screening Capsule to Redefine Colorectal Cancer Screening and Prevention
29. Regional Brain Activation in Response to Rectal Distension in Patients with Irritable Bowel Syndrome and the Effect of a History of Abuse
30. Syndrome du côlon irritable
31. Contributeurs
32. Biofeedback treatment of fecal incontinence: A critical review
33. Contributors
34. Irritable Bowel Syndrome
35. Prebiotics and the Health Benefits of Fiber: Current Regulatory Status, Future Research, and Goals1,2
36. Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
37. Dietary prebiotics: current status and new definition
38. 397 MICROBIOME GENOMICS REVEALS NOVEL BACTERIAL STRAINS ASSOCIATED WITH IRRITABLE BOWEL SYNDROME SYMPTOMS AND DISEASE SEVERITY.
39. Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease
40. The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans
41. The Burden of Gastrointestinal and Liver Diseases, 2006
42. Digestive and liver diseases statistics, 2004
43. Functional Chest Pain of Presumed Esophageal Origin
44. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis
45. Tu1774 – Microbiome Functionalgenomics Reveals Novel Bacterial Strains for Reduction of Inflammation in Crohn's Disease
46. Mo1715 – The Israeli Multi Center “Swallow and Forget” Study: Prepless X-Ray Imaging Capsule with Enhanced Algorithms Shows Substantial Improvement in Polyp Detection
47. Sa1685 – Proteomic Characterization of IBS Vs Control Plasma Samples Via Two Complementary Methods: Somascan and Rplc Ms/Ms
48. 1100 – Reduced Bacteria-Derived Bile Salt Hydrolase Enzymatic Activity - a Possible Mechanism for Symptoms Severity in Patients with Irritable Bowel Syndrome
49. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities
50. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.